NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)END SEPSIS INC, founded in 2015, is a small nonprofit in the Diseases & Disorders sector that reported $368K in total revenue in fiscal year 2020. Revenue fell 29% from the prior year — a significant decline worth monitoring.
EDUCATIONWE BELIEVE THAT THE RESPONSIBILITY FOR ENDING SEPSIS BELONGS TO ALL OF USAND THATYOUNG PEOPLE HAVE AN ESPECIALLY CRITICAL ROLE TO PLAY. THE END SEPSIS FOUNDATIONFOR SEPSIS PREVENTION HAS DEVELOPED THE FIRST COMPREHENSIVE K-12 SEPSIS CURRICULUM TOPROGRESSIVELY EDUCATE SCHOOL STUDENTS ABOUT INFECTION AND SEPSIS AND TO EQUIP THEM TOBECOME EFFECTIVE ADVOCATES IN THEIR COMMUNITIES. OUR GOAL IS TO REDUCE INSTANCES OFINFECTION AND ENSURE THAT EVERY YOUNG PERSON KNOWS THE SIGNS OF SEPSIS.THE NATIONAL FAMILY COUNCIL ON SEPSISTHE NATIONAL FAMILY COUNCIL ON SEPSIS IS A NETWORK OF FAMILIES THAT HAVE LOST A LOVEDTO SEPSIS AND SEPSIS SURVIVORS. ESTABLISHED IN 2015, BY THE END SEPSIS FOUNDATIONTHE COUNCIL WORKS AT THE FEDERAL, STATE, AND LOCAL LEVELS TO SUPPORT THE MISSION OFEND SEPSIS. THROUGH ITS PASSION AND COMMITMENT TO DRIVING REAL CHANGE, THE COUNCILHAS BECOME THE LEADING FORCE IN THE FIGHT TO END PREVENTABLE DEATHS AND DISABILITIESFROM SEPSIS.
EACH YEAR, THE END SEPSIS FOUNDATION FOR SEPSIS PREVENTION HOSTS THE NATIONAL FORUM ON SEPSIS FEATURING THE BEST AND THE BRIGHTEST IN HEALTHCARE POLICY, GOVERNMENT, CRITICAL CARE, PATIENT ADVOCACY...
EACH YEAR, THE END SEPSIS FOUNDATION FOR SEPSIS PREVENTION HOSTS THE NATIONAL FORUM ON SEPSIS FEATURING THE BEST AND THE BRIGHTEST IN HEALTHCARE POLICY, GOVERNMENT, CRITICAL CARE, PATIENT ADVOCACY, AND BIOTECHNOLOGY TO IDENTIFY AND ADDRESS CHALLENGES AND OPPORTUNITIES IN THE SEPSIS CRISIS. THE FORUM PROVIDES AN OPPORTUNITY TO DISCUSS PROGRESS AND FORGE NEW COMMITMENTS, AND BUILD STRONG COALITIONS AS WE WORK TO REDUCE THE BURDEN OF SEPSIS ON OUR SOCIETY AND OUR FAMILIES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2020 | 2019 | Change | |
|---|---|---|---|
| Revenue | $367,886 | $514,727 | -0.3% |
| Expenses | $378,840 | $411,341 | -0.1% |
| Net Income | $-10,954 | $103,386 | -1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| CIARAN STAUNTON | DIRECTOR | 40.00 |
Officer
Director
|
$53,000 | $0 | $53,000 |
| NIALL O'DOWD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ROSEMARY DEVLIN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| LUCIA DESPAGNO | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ANNE GOLDMAN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DR EDWARD CONWAY | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ORLAITH STAUNTON | CO-FOUNDER | 30.00 |
Highest
|
$142,000 | $0 | $142,000 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2020 | $367,886 | $378,840 | $478,053 | $-10,954 |
| 2019 | $514,727 | $411,341 | $488,313 | $103,386 |
| 2018 | $566,400 | $455,870 | $385,760 | $110,530 |
Compare END SEPSIS INC with other nonprofits in New York and across the country.